“…15 Therefore, gastrointestinal exposure is an important exposure route for PM. Several previous studies have linked PM exposure with increased risks of gastrointestinal diseases such as oesophageal cancer, IBD, and IBS, 5,7,26,27 It is reported that PM exposure could increase ROS generation, induce gastrointestinal epithelial cell death, and induce the disruption and hyperpermeability of the intestinal barrier. 34,35 Moreover, animal studies observed that PM exposure was associated with increased inflammatory cell infiltration, inflammation-related genes ( IL-6 , IL-10 , IL-1β , and TNF-α ) expression, and intestinal inflammation in the colon, 35–37 which provided experimental evidence on the association between PM exposure and intestinal inflammation.…”